Advertisement Sun Pharma launches generic Ethyol - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sun Pharma launches generic Ethyol

Sun Pharmaceutical Industries has commercially launched generic Amifostine for injection 500mg, which is therapeutically equivalent to MedImmune's Ethyol.

Sun Pharma’s product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories. Sun Pharma had received a FDA approval for this earlier in March 2008. Sun Pharma, being the first-to-file an ANDA for generic Ethyol with a para IV certification, has a 180-day marketing exclusivity.